CAS 66104-23-2
:Pergolide mesylate
Description:
Pergolide mesylate is a synthetic compound primarily used in the treatment of Parkinson's disease and certain conditions related to hyperprolactinemia. It acts as a dopamine receptor agonist, specifically targeting D2 and D1 receptors, which helps to alleviate symptoms associated with dopamine deficiency. The substance is characterized by its mesylate salt form, which enhances its solubility and bioavailability. Pergolide mesylate is typically administered orally and is known for its relatively long half-life, allowing for once-daily dosing in some cases. Its chemical structure includes a bicyclic core, which is essential for its pharmacological activity. While effective, pergolide mesylate has been associated with side effects such as nausea, dizziness, and, in some cases, more severe complications like cardiac valvulopathy. Due to safety concerns, its use has been limited, and it is often prescribed when other treatments are not suitable. Overall, pergolide mesylate exemplifies the complexities of pharmacotherapy in managing chronic neurological conditions.
Formula:C19H26N2S·CH4O3S
InChI:InChI=1S/C19H26N2S.CH4O3S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21;1-5(2,3)4/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3;1H3,(H,2,3,4)/t13-,16-,18-;/m1./s1
InChI key:InChIKey=UWCVGPLTGZWHGS-ZORIOUSZSA-N
SMILES:C(CC)N1[C@]2([C@@](C=3C=4C(C2)=CNC4C=CC3)(C[C@@H](CSC)C1)[H])[H].S(C)(=O)(=O)O
Synonyms:- 8-beta-((Methylthio)methyl)-6-propylergoline methanesulfonate
- 8-beta-((Methylthio)methyl)-6-propylergoline monomethane sulfonate
- 8beta-((Methylthio)methyl)-6-propylergoline monomethanesulfonate
- Celance
- Ergoline, 8-((methylthio)methyl)-6-propyl-, monomethanesulfonate, (8beta)-
- Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8β)-, monomethanesulfonate
- Ergoline, 8-beta-((methylthio)methyl)-6-propyl-, methanesulfonate (1:1)
- Indolo[4,3-fg]quinoline, ergoline deriv.
- Ly 127809
- Ly127809
- MPE
- NSC 319773
- Pergolide mesylate salt
- Pergolide methanesulfonate
- Permax
- Unii-55B9Hqy616
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
PERGOLIDE MESILATE CRS
CAS:PERGOLIDE MESILATE CRSFormula:C20H30N2O3S2Color and Shape:PowderMolecular weight:410.5938Pergolide Mesylate
CAS:Alkaloids of rye ergot and their derivatives; salts thereof, nesoiFormula:C19H26N2S·CH4O3SColor and Shape:White Off-White PowderMolecular weight:314.18167Pergolide mesylate
CAS:Formula:C19H26N2S·CH4O3SPurity:≥ 98.0%Color and Shape:White to off-white crystalline powderMolecular weight:410.59Pergolide Mesilate
CAS:Controlled ProductFormula:C19H26N2S·CH4O3SColor and Shape:NeatMolecular weight:410.59Pergolide mesilate
CAS:Controlled ProductFormula:C19H26N2S·CH4O3SColor and Shape:NeatMolecular weight:410.59Pergolide mesylate
CAS:Pergolide mesylate (LY127809), a dopamine agonist for Parkinson's and hyperprolactinemia, was withdrawn for heart valve risk.Formula:C20H30N2O3S2Purity:99.70%Color and Shape:White To Off-White SolidMolecular weight:410.59Pergolide Mesylate-d7
CAS:Controlled Product<p>Applications A dopaminergic agonist that also decrease plasma prolactin concentrations. A labelled antiparkinsonian agent.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lemberger, L. and Crabtree, R.E.: Science, 205, 1151 (1979), Koller, W.C.: Neuropharmacology, 19, 831 (1980), Francks, S., et al.: Lancet, 2, 659 (1981), Kleinberg, D.L., et al.: N. Engl. J. Med., 309, 704 (1983)<br></p>Formula:C20H23D7N2O3S2Color and Shape:NeatMolecular weight:417.64Pergolide Mesylate
CAS:Controlled ProductFormula:C19H26N2S·CH4O3SColor and Shape:NeatMolecular weight:410.59Pergolide mesylate
CAS:Controlled Product<p>D1 and D2 dopamine agonist</p>Formula:C20H30N2O3S2Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:410.6 g/mol









